Stock & Company Details
Fortrea Holdings Inc $FTRE
Price:
N/A
N/A
97M
$1.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
-22.13
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
FTRE technical indicators
Latest Fortrea Holdings Inc (FTRE) indicator readings as of 2026-11-19.
FTRE's 14-day RSI is 44.7, in neutral territory. ADX reads 19.7, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.40, below the zero line.
Overview
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Finance Bot
Ask your questions
Start by typing a question below.